Status:
COMPLETED
Direct and Indirect Benefits of Influenza Vaccine Versus Placebo in Healthy Children
Lead Sponsor:
The University of Hong Kong
Collaborating Sponsors:
Research Fund for the Control of Infectious Diseases
Research Grants Council, Hong Kong
Conditions:
Influenza Virus Infection
Eligibility:
All Genders
Phase:
NA
Brief Summary
While immunisation of school-age children against influenza is not recommended in Hong Kong, past experience in Japan and elsewhere suggests that immunisation of children may protect the wider communi...
Detailed Description
Design and subjects: A double-blind randomised controlled trial of 800 subjects aged 6-17 drawn from the general population and their 2000 household contacts. The subjects will be randomised in a 3:2 ...
Eligibility Criteria
Inclusion
- All vaccinees must be Hong Kong residents aged between 6 and 17.
Exclusion
- Vaccinees should not be allergic or hypersensitive to the active substances or components (eggs, chicken proteins, formaldehyde, neomycin, etc.) used in the vaccines or where vaccination is otherwise contraindicated. Subjects should not have an underlying immunocompromised condition or be receiving immunosuppressive agents.
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2010
Estimated Enrollment :
2800 Patients enrolled
Trial Details
Trial ID
NCT00792051
Start Date
September 1 2008
End Date
December 1 2010
Last Update
December 30 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Hong Kong
Hong Kong, China